Dotarem FDA Approval History
FDA Approved: Yes (First approved March 20, 2013)
Brand name: Dotarem
Generic name: gadoterate meglumine
Dosage form: Injection
Treatment for: Diagnosis and Investigation
Dotarem (gadoterate meglumine) is a gadolinium-based contrast agent indicated for use in magnetic resonance imaging (MRI).
Development Timeline for Dotarem
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.